The latest research study “Oncology Information Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global oncology information systems market size reached US$ 3.41 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 5.35 Billion by 2027 exhibiting a CAGR of 7.50% during 2022-2027.
Get Full Report with TOC & List of Figure: https://www.imarcgroup.com/oncology-information-systems-market
An oncology information system (OIS) is software designed to optimize patient profiles, diagnose, and identify suitable cancer therapy to improve survival rates. It involves analysis, screening, treatment, prevention, and palliative care. Compared to traditional techniques, these systems offer planned treatment, remote access, future prediction, and proper clinical and non-clinical data management, ensuring optimal use of resources to support efficient workflow and keep track of diagnostic details and treatment patterns. Owing to these properties, OIS is widely adopted in hospitals, clinics, laboratories, and research centers.
Covid-19 Impact :
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample Copy for more detailed market insights: https://www.imarcgroup.com/oncology-information-systems-market/requestsample
Oncology Information Systems Market Trends and Drivers:
The market is primarily driven by the increasing prevalence of cancer among the masses due to the consumption of tobacco-based products and sedentary lifestyles. Along with this, the sudden outbreak of the coronavirus disease (COVID-19) pandemic and the consequent implementation of mandatory lockdowns have escalated the demand for OIS solutions across the healthcare industry.
Moreover, significant technological advancements, such as the incorporation of blockchain and artificial intelligence (AI) to mitigate the errors of paper-based record creation, prescriptions, and treatment plans, and the development of electronic health records (EHRs) to save time and cost, are acting as other growth-inducing factors. Moreover, governments of numerous countries are extensively funding research and development (R&D) activities to develop remote oncology information systems and encourage healthcare practitioners to perform long-term monitoring of cancer through mobile applications without being physically present with the patient.
This, coupled with growing consumer awareness regarding the availability of cancer monitoring systems and the increasing utilization of OIS to perform immunotherapy and radiation therapy, is also creating a positive market outlook across the globe.
The report has been segmented the market into following categories:
Breakup by Product and Services:
- Patient Information Systems
- Treatment Planning Systems
- Consulting Services
- Implementation Services
- Maintenance Services
Breakup by Application:
- Radiation Oncology
- Medical Oncology
- Surgical Oncology
Breakup by End User:
- Hospitals and Diagnostic Imaging Centers
- Ablation Care Centers and Cancer Care Centers
- Government Institutions
- Research Facilities
Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
•Middle East and Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
List of Major Key Players:
The major players in the market are Accuray Incorporated (NASDAQ: ARAY), Advanced Data Systems (NYSE: BFH), Cerner Corporation (Oracle Corporation), CureMD Healthcare, Elekta, EndoSoft LLC (Utech Products Inc.), F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., McKesson Corporation, OPTUM Inc. (United Healthcare Services Inc.), RaySearch Laboratories and Varian Medical Systems Inc.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us: IMARC Services Private Limited. 30 N Gould St Ste R Sheridan, WY 82801 USA – Wyoming Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800